Aluminum bone disease
ICD-10 M83.4 is a billable code used to indicate a diagnosis of aluminum bone disease.
Aluminum bone disease, also known as aluminum-related bone disease, is a condition characterized by the accumulation of aluminum in the bones, leading to impaired bone metabolism and density. This condition is often associated with chronic renal failure, where patients may be exposed to aluminum through phosphate binders or contaminated dialysis water. The presence of aluminum disrupts normal bone remodeling processes, resulting in osteomalacia, a condition where bones become soft due to inadequate mineralization. Patients may experience bone pain, increased risk of fractures, and skeletal deformities. Diagnosis typically involves a combination of clinical evaluation, imaging studies, and laboratory tests to assess aluminum levels in the body. Treatment focuses on reducing aluminum exposure, managing underlying renal conditions, and addressing bone health through supplementation and lifestyle modifications. Monitoring bone density is crucial, as patients with aluminum bone disease are at a heightened risk for osteoporosis and fractures, necessitating a multidisciplinary approach to care.
Detailed history of renal function, aluminum exposure sources, and treatment plans.
Patients with chronic kidney disease on dialysis presenting with bone pain or fractures.
Close monitoring of aluminum levels and renal function is essential for accurate coding.
Assessment of bone density, metabolic panel results, and treatment for osteoporosis.
Patients with metabolic bone disease requiring evaluation for aluminum-related effects.
Documentation should include details on bone density tests and any interventions for osteoporosis.
Used to assess bone density in patients suspected of having aluminum bone disease.
Include results of the bone density scan and any relevant clinical findings.
Endocrinologists should document the rationale for the test in relation to aluminum exposure.
Aluminum bone disease is a condition caused by the accumulation of aluminum in the bones, often seen in patients with chronic kidney disease. It leads to impaired bone metabolism and increased risk of fractures.
Diagnosis involves clinical evaluation, imaging studies, and laboratory tests to measure aluminum levels in the body. Symptoms may include bone pain and fractures.
Treatment focuses on reducing aluminum exposure, managing underlying renal conditions, and addressing bone health through supplementation and lifestyle changes.
